{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:22:19Z","timestamp":1769167339883,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T00:00:00Z","timestamp":1377561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/bjc.2013.504","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T19:57:10Z","timestamp":1377633430000},"page":"1813-1820","source":"Crossref","is-referenced-by-count":34,"title":["Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma"],"prefix":"10.1038","volume":"109","author":[{"given":"T M","family":"Meniawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,27]]},"reference":[{"key":"BFbjc2013504_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/sj.bjc.6601907","volume":"91","author":"A Burton","year":"2004","unstructured":"Burton A, Altman DG (2004) Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer 91: 4\u20138.","journal-title":"Br J Cancer"},{"key":"BFbjc2013504_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15: 257\u2013260.","journal-title":"Ann Oncol"},{"key":"BFbjc2013504_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","volume":"77","author":"S Cedres","year":"2012","unstructured":"Cedres S, Montero MA, Martinez P, Martinez A, Rodriguez-Freixinos V, Torrejon D, Gabaldon A, Salcedo M, Ramon YCS, Felip E (2012) Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM). Lung Cancer 77: 192\u2013198.","journal-title":"Lung Cancer"},{"key":"BFbjc2013504_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","volume":"16","author":"D Curran","year":"1998","unstructured":"Curran D, Sahmoud T, Therasse P, Van Meerbeeck J, Postmus PE, Giaccone G (1998) Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16: 145\u2013152.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013504_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/thorax.55.9.731","volume":"55","author":"JG Edwards","year":"2000","unstructured":"Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55: 731\u2013735.","journal-title":"Thorax"},{"key":"BFbjc2013504_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1200\/JCO.2005.07.050","volume":"23","author":"DA Fennell","year":"2005","unstructured":"Fennell DA, Parmar A, Shamash J, Evans MT, Sheaff MT, Sylvester R, Dhaliwal K, Gower N, Steele J, Rudd R (2005) Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol 23: 184\u2013189.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013504_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","volume":"48","author":"RJ Francis","year":"2007","unstructured":"Francis RJ, Byrne MJ, Van Der Schaaf AA, Boucek JA, Nowak AK, Phillips M, Price R, Patrikeos AP, Musk AW, Millward MJ (2007) Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med 48: 1449\u20131458.","journal-title":"J Nucl Med"},{"key":"BFbjc2013504_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.113.3.723","volume":"113","author":"JE Herndon","year":"1998","unstructured":"Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113: 723\u2013731.","journal-title":"Chest"},{"key":"BFbjc2013504_CR9","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1200\/JCO.2011.38.7589","volume":"30","author":"JG Ibrahim","year":"2012","unstructured":"Ibrahim JG, Chu H, Chen M-H (2012) Missing data in clinical studies: issues and methods. J Clin Oncol 30: 3297\u20133303.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013504_CR10","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/JTO.0b013e31822a3740","volume":"6","author":"SC Kao","year":"2011","unstructured":"Kao SC, Klebe S, Henderson DW, Reid G, Chatfield M, Armstrong NJ, Yan TD, Vardy J, Clarke S, Van Zandwijk N, Mccaughan B (2011) Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy. J Thorac Oncol 6: 1923\u20131929.","journal-title":"J Thorac Oncol"},{"key":"BFbjc2013504_CR11","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, Van Zandwijk N, Clarke SJ (2010) High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 16: 5805\u20135813.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2013504_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cllc.2012.03.011","volume":"14","author":"SC Kao","year":"2013","unstructured":"Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, Van Zandwijk N, Clarke S (2013) Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clin Lung Cancer 14: 70\u201377.","journal-title":"Clin Lung Cancer"},{"key":"BFbjc2013504_CR13","doi-asserted-by":"crossref","unstructured":"Little RJ, D\u2019agostino R (2012) The prevention and treatment of missing data in clinical trials. N Engl J Med 1355\u20131360.","DOI":"10.1056\/NEJMsr1203730"},{"key":"BFbjc2013504_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","volume":"12","author":"DC Mcmillan","year":"2009","unstructured":"Mcmillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12: 223\u2013226.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFbjc2013504_CR15","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM Mcshane","year":"2005","unstructured":"Mcshane LM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23: 9067\u20139072.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013504_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","volume":"7","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R (2012) Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol 7: 587\u2013594.","journal-title":"J Thorac Oncol"},{"key":"BFbjc2013504_CR17","first-page":"271","volume-title":"AJCC Cancer Staging Manual","author":"SB Edge","year":"2010","unstructured":"Pleural mesothelioma (2010) In AJCC Cancer Staging Manual Edge SB, Byrd DR, Crompton CC, Fritz AG, Greene FL, Trotti A (eds). 7th edn. pp 271\u2013277. Springer: New York, NY."},{"key":"BFbjc2013504_CR18","unstructured":"R Core Team (2013) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria."},{"key":"BFbjc2013504_CR19","volume-title":"Analysis of Incomplete Multivariate Data","author":"J Schafer","year":"1977","unstructured":"Schafer J (1977) Analysis of Incomplete Multivariate Data. Chapman & Hall: London."},{"key":"BFbjc2013504_CR20","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00262-011-1073-8","volume":"60","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Kadota K, Sima CS, Sadelain M, Rusch VW, Travis WD, Adusumilli PS (2011) Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. Cancer Immunol Immunother 60: 1721\u20131728.","journal-title":"Cancer Immunol Immunother"},{"key":"BFbjc2013504_CR21","first-page":"1","volume":"45","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren S, Groothuis-Oudshoorn K (2011) mice: Multivariate Imputation by Chained Equations in R. J Stat Softw 45: 1\u201367.","journal-title":"J Stat Softw"},{"key":"BFbjc2013504_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636\u20132644.","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013504","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:17:53Z","timestamp":1684415873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFbjc2013504"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.504","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,27]]}}}